New Delhi: Poyankha pempho la Fresenius Medical Care, Komiti Yodziwika Bwino (SEC) ya Central Drugs Standard Control Organisation (CDSCO) yalangiza kampaniyo kuti ipereke zifukwa zovomerezeka pamodzi ndi deta ya mayeso azachipatala a gawo lachitatu la calcium chloride dihydrate ndi deta yowunikira pambuyo pa malonda kuchokera kumayiko ovomerezeka kuti aganizirenso zina.
Kampaniyo kale idapereka fomu yopempha kuti ipange ndikugulitsa yankho la calcium chloride dihydrate pamlingo wa 100 mmol/L, lomwe limagwiritsidwa ntchito pa "calcium replacement therapy mu continuous renal replacement therapy (CRRT), continuous low-efficiency (tsiku ndi tsiku) dialysis (CLED) ndi therapeutic plasma exchange (TPE) yokhala ndi citrate anticoagulation. Mankhwalawa ndi oyenera akuluakulu ndi ana" ndipo adatchula zifukwa zopewera mayeso azachipatala a gawo lachitatu ndi lachinayi.
Komitiyi yaona kuti mankhwalawa avomerezedwa m'maiko aku Europe monga Portugal, United Kingdom, Brazil, Switzerland, France ndi Denmark.
Kashiamu chloride dihydrate yophatikizika ndi CaCl2 2H2O, yomwe ndi calcium chloride yokhala ndi mamolekyu awiri amadzi pa unit iliyonse ya calcium chloride. Ndi chinthu choyera cha kristalo, chomwe chimasungunuka mosavuta m'madzi ndipo chimakhala ndi hygroscopic, mwachitsanzo, chomwe chimatha kuyamwa chinyezi kuchokera mumlengalenga.
Calcium chloride dihydrate ndi mankhwala omwe angagwiritsidwe ntchito ngati njira yosungunulira chitin ikasungunuka mu methanol. Imagwira ntchito yofunika kwambiri pakuswa kapangidwe ka kristalo ka chitin ndipo imagwiritsidwa ntchito m'njira zosiyanasiyana m'munda wa chemistry.
Pa msonkhano wa SEC Nephrology womwe unachitika pa Meyi 20, 2025, gululo linawunikanso lingaliro lovomereza kupanga ndi kugulitsa kwa 100 mmol/L calcium chloride dihydrate infusion solution kuti igwiritsidwe ntchito mu "calcium replacement therapy in continuous renal replacement therapy (CRRT), continuous low-efficiency (tsiku ndi tsiku) dialysis (SLEDD), ndi therapeutic plasma exchange (TPE) ndi citrate anticoagulation. Mankhwalawa amaperekedwa kwa akuluakulu ndi ana" ndipo adapereka zifukwa zochotsera mayeso azachipatala a gawo lachitatu ndi lachinayi.
Pambuyo pokambirana mwatsatanetsatane, komitiyi idalimbikitsa kuti maziko ovomerezera, komanso deta ya mayeso azachipatala a gawo lachitatu ndi deta yowunikira pambuyo pa malonda kuchokera kumayiko omwe avomereza mankhwalawa, aperekedwe ku komitiyi kuti aganizirenso zina.
Werenganinso: Gulu la CDSCO Lavomereza Kusinthidwa kwa Zolemba za Sanofi's Myozyme, Lapempha Kuwunikanso kwa Malamulo
Dr. Divya Kolin ndi wophunzira wa PharmD yemwe ali ndi luso lalikulu la zachipatala ndi zachipatala komanso luso lapamwamba lofufuza matenda ndi kuchiza matenda. Wagwiranso ntchito ngati wamankhwala wa khansa mu dipatimenti ya khansa ku Mysore Medical College and Research Institute. Pakadali pano akuchita ntchito yake yofufuza zachipatala komanso kasamalidwe ka deta yachipatala. Wakhala akugwira ntchito ndi Medical Dialogue kuyambira Januware 2022.
       Dr Kamal Kant Kohli, MBBS, MD, CP, is a thoracic specialist with over 30 years of experience and specializes in clinical writing. He joins Medical Dialogues as the Editor-in-Chief of Medical News. Apart from writing articles, as the Editor, he is responsible for proofreading and reviewing all medical content published in Medical Dialogues, including content from journals, research papers, medical conferences, guidelines, etc. Email: drkohli@medicaldialogues.in Contact: 011-43720751
Kafukufuku wa ABYSS adapeza kuti kusiya kugwiritsa ntchito beta-blockers pambuyo pa infarction ya myocardial kunapangitsa kuti kuthamanga kwa magazi, kugunda kwa mtima, ndi zochitika zoyipa za mtima ndi mitsempha yamagazi ziwonjezeke: ...